Inventor
VAN GEEL REMON
NL13 patents
⚠️ This page may combine multiple inventors who share the name “VAN GEEL REMON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNAFFIX BV
12 patentsUS9504758B2Nov 29, 2016
Modified antibody, antibody-conjugate and process for the preparation thereof
SYNAFFIX BV65 citations97
US10266502B2Apr 23, 2019
Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne
SYNAFFIX BV78 citations96
US9988661B2Jun 5, 2018
Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from A β(1,4)-N-acetylgalactosaminyltransferase
SYNAFFIX BV5 citations83
US11338043B2May 24, 2022
Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugates
SYNAFFIX BV8 citations82
US10072096B2Sep 11, 2018
Modified glycoprotein, protein-conjugate and process for the preparation thereof
SYNAFFIX BV9 citations82
US9987373B2Jun 5, 2018
Modified glycoprotein, protein-conjugate and process for the preparation thereof
SYNAFFIX BV3 citations72
US12194107B2Jan 14, 2025
Modified antibody, antibody-conjugate and process for the preparation thereof
SYNAFFIX BV0 citations62
US12049656B2Jul 30, 2024
Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferase
SYNAFFIX BV0 citations61
US11951175B2Apr 9, 2024
Bioconjugates containing sulfamide linkers for use in treatment
SYNAFFIX BV1 citations61
US11299759B2Apr 12, 2022
Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferase
SYNAFFIX BV1 citations61
US11713453B2Aug 1, 2023
Enzymes for trimming of glycoproteins
SYNAFFIX BV0 citations60
US12440573B2Oct 14, 2025
Antibody-conjugates for targeting of tumours expressing PTK7
SYNAFFIX BV0 citations56